The coffee industry remains a formidable sector in global markets, particularly as new scientific studies highlight potential health benefits related to consumption patterns. As 2025 approaches, coffee continues to be not only a key commodity in international trade but also a significant part of
Drawing from years of experience in biopharmaceutical research and innovation, Ivan Kairatov is known for his insightful contributions to healthcare advancements. With the recent recognition of Tagomics Ltd. through a substantial grant from Innovate UK for colorectal cancer research, Ivan is poised
Pancreatic cancer remains a formidable challenge in the medical field, with its survival rates trailing behind those of many other cancers despite advances in treatment options. The Lustgarten Foundation, recognized as the leading private funder of pancreatic cancer research worldwide, is committed
In an era where personalized medicine is increasingly becoming the norm, microbiome science is emerging as a pivotal player in reshaping patient care. Understanding the intricate relationship between human health and the billions of microbes that inhabit our bodies presents a unique opportunity. By
Ivan Kairatov is a highly respected biopharma expert who has made significant contributions to the understanding and innovation in cancer research. With a focus on neuroblastoma, a particularly aggressive childhood cancer, his work is paving the way for new treatment strategies. In this interview,
In recent years, the intersection of biotechnology and plant biology has led to transformative developments in drug production, highlighting a pivotal turning point in the sustainable manufacturing of vital medicines. Among these advancements is the use of tobacco plants to synthesize baccatin III,